MedPath
FDA Approval

Acamprosate Calcium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 1, 2016
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Acamprosate(333 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Acamprosate Calcium

Product Details

NDC Product Code
10135-636
Application Number
ANDA202229
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 25, 2019
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
MAGNESIUM SILICATEInactive
Code: 9B9691B2N9Class: IACT
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE AInactive
Code: NX76LV5T8JClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
Code: 59375N1D0UClass: ACTIBQuantity: 333 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
© Copyright 2025. All Rights Reserved by MedPath